Rationale for combined blockade of PD-1 and CTLA-4 in advanced head and neck squamous cell cancer – Review of current data

Title
Rationale for combined blockade of PD-1 and CTLA-4 in advanced head and neck squamous cell cancer – Review of current data
Authors
Keywords
Nivolumab, Ipilimumab, Head and neck cancer, PD-1, CTLA-4, Immunotherapy
Journal
ORAL ONCOLOGY
Volume 51, Issue 1, Pages 12-15
Publisher
Elsevier BV
Online
2014-10-28
DOI
10.1016/j.oraloncology.2014.10.010

Ask authors/readers for more resources

Reprint

Contact the author

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started